Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model

Journal of Virology

Volumn 73, Issue 10, 1999, Pages 8160-8166

  Kucerova, Lucia ^a   Altanerova, Veronika ^a   Altaner, Cestmir ^a   Boris Lawrie, Kathleen ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE LEUKEMIA VIRUS; CLONING VECTOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IMMUNOGENICITY; LONG TERMINAL REPEAT; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; VACCINATION;

EID: 0032844227     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.10.8160-8166.1999     Document Type: Article

References (44)

1. Akagi, T., J. Ono, H. Nyunoya, and K. Shimotohno. 1997. Characterization of peripheral blood T lymphocytes transduced with human T-cell leukemia virus type I Tax mutants with different trans-activating phenotypes. J. Virol. 14:2071-2078.
2. Alexandersen, S., S. Carpenter, J. Christensen, T. Storgaard, B. Viuff, Y. Wannemuehler, J. Belousov, and J. A. Roth. 1993. Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J. Virol. 67:39-52.
3. Altaner, C., M. Merza, V. Altanerova, and B. Morein. 1993. Envelope glycoprotein gp51 of bovine leukemia virus is differently glycosylated in cells of various species and organ origin. Vet. Immunol. Immunopathol. 36:163-177.
4. Altanerova, V., J. Ban, and C. Altaner. 1989. Induction of immune deficiency syndrome in rabbits by bovine leukemia virus. AIDS 3:775-780.
5. Altanerova, V., D. Portetelle, R. Kettman, and C. Altaner. 1989. Infection of rats with bovine leukemia virus: establishment of a virus-producing rat cell line. J. Gen. Virol. 70:1929-1932.
6. Boris-Lawrie, K., and H. M. Temin. 1995. Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex. J. Virol. 69:1920-1924.
7. Boris-Lawrie, K., V. Altanerova, C. Altaner, L. Kucerova, and H. M. Temin. 1997. In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex. J. Virol. 71:1514-1520.
8. Burny, A., Y. Cleuter, R. Kettman, M. Mammerickx, G. Marbaix, D. Portetelle, A. Van den Broeke, L. Willems, and R. Thomas. 1987. Bovine leukemia virus: facts and hypotheses derived from the study of an infectious cancer. Cancer Surv. 6:139-159.
9. Butsch, M., S. Hull, Y. Wang, T. M. Roberts, and K. Boris-Lawrie. 1999. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production. J. Virol. 73:4847-4855.
10. Cockerell, G. L., J. Rovnak, P. L. Green, and I. S. Y. Chen. 1996. A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo. Blood 87:1030-1035.
11. 1 reduces viral infectivity in vivo. Blood 91:4701-4707.
12. Dequiedt, F., E. Hanon, P. Kerkhofs, P. P. Pastoret, D. Portetelle, A. Burny, R. Kettman, and L. Willems. 1997. Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J. Virol. 71:630-639.
13. Derse, D. 1987. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements. J. Virol. 61:2462-2471.
14. Derse, D. 1988. trans-acting regulation of bovine leukemia virus mRNA processing. J. Virol. 62:1115-1119.
15. Derse, D., J. Mikovits, and F. Ruscetti. 1997. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 237:123-128.
16. Djilali, S., and A.-L. Parodi. 1989. The BLV-induced leukemia-lymphosarcoma complex in sheep. Vet. Immunol. Immunopathol. 22:233-244.
17. Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86:3619-3639.
18. Grassman, R., S. Berchtolds, I. Radant, M. Alt, B. Fleckenstein, J. G. Sodroski, W. A. Haseltine, and U. Ramstedt. 1992. Role of the human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66:4570-4575.
19. Green, P. L., M. T. Yip, Y. Xie, and I. S. Y. Chen. 1992. Phosphorylation regulates RNA binding by the human T-cell leukemia virus Rex protein. J. Virol. 66:4325-4330.
20. Grossman, W. J., J. T. Kimata, F. H. Wong, M. Zutter, T. J. Ley, and L. Ratner. 1995. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type 1. Proc. Natl. Acad. Sci. USA 92:1057-1061.
21. Hanley, S. M., L. T. Rimsky, M. H. Malim, J. H. Kim, J. Hauber, M. Duc Dondon, S.-Y. Le, J. V. Maizel, B. R. Cullen, and W. C. Greene. 1989. Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev. 3:1534-1544.
22. Hislop, A. D, M. F. Good, L. Mateo, J. Gardner, M. H. Gatei, R. C. W. Daniel, B. V. Meyers, M. Lavin, and A. Schurbier. 1998. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge. Nat. Med. 4:1193-1196.
23. Hope, T., and R. J. Pomerantz. 1995. The human immunodeficiency virus type 1 Rev protein: a pivotal protein in the viral life cycle. Curr. Top. Microbiol. Immunol. 193:91-105.
24. Jensen, W. A., J. Rovnak, and G. L. Cockerell. 1991. In vivo transcription of bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep. J. Virol. 65:2484-2490.
25. Kettmann, R., A. Burny, I. Callebaut, L. Droogmans, M. Mammerickx, L. Willems, and D. Portetelle. Bovine leukemia virus, p 39-81. In J. A. Levy (ed.), The Retroviridae, vol. 3. Plenum Press, New York, N.Y.
26. Kerkhofs, P., H. Heremans, A. Burny, R. Kettmann, and L. Willems. 1998. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J. Virol. 72:2554-2559.
27. Lew, D., S. E. Parker, T. Latimer, A. M. Abai, A. Kuwahara-Rundell, S. G. Doh, Z. Yang, D. Laface, S. H. Gromkowski, G. J. Nabel, M. Manthorpe, and J. Norman. 1995. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6:553-564.
28. Mammerickx, M., R. Palm, D. Portetelle, and A. Burny. 1988. Experimental transmission of enzootic bovine leukosis to sheep: latency period of the tumoral disease. Leukemia 2:103-107.
29. Mirsky, M. L., C. A. Olmstead, Y. Da, and H. A. Lewin. 1996. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subdinical stages of infection. J. Viral. 70:2178-2183.
30. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D. D. Ho, D. F. Nixon, and A. J. McMichael. 1998. Quantification of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-2106.
31. Paul, P. S., K. A. Pomeroy, D. W. Johnson, C. C. Muscoplat, B. S. Handwerger, F. F. Soper, and D. K. Sorenson. 1977. Evidence for the replication of bovine leukemia virus in B lymphocytes. Am. J. Vet. Res. 38:873-876.
32. Powers, M. A., and K. Radke. 1992. Activation of bovine leukemia virus transcription in lymphocytes from infected sheep: rapid transition through early to late gene expression. J. Virol. 66:4769-4777.
33. Radke, K., D. Grossman, and L. C. Kidd. 1990. Humoral immune response of experimentally infected sheep defines two early periods of bovine leukemia virus replication. Microb. Pathog. 9:159-171.
34. Ressler, S., L. M. Connor, and S. J. Marriott. 1996. Cellular transformation by human T-cell leukemia virus type I. FEMS Microbiol. Letters 140:99-109.
35. Ross, T. M., S. M. Pettiford, and P. L. Green. 1996. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J. Virol. 70:5194-5202.
36. Temin, H. M. 1993. A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA 9:4419-4420.
37. Valentin, A., G. Aldrovandi, A. S. Zolotukhin, S. W. Cole, J. A. Zack, G. N. Pavlakis, and B. K. Felber. 1997. Reduced viral load and lack of CD4 depletion in SCID-hu mice infected with Rev-independent clones of human immunodeficiency virus. J. Virol. 71:9817-9822.
38. Willems, L., A. Gegonne, G. Chen, R. Kettmann, and J. Ghysdael. 1987. The bovine leukemia virus p34 is a transactivator protein. EMBO J. 6:3385-3389.
39. Willems, L., H. Heremans, G. Chen, D. Portetelle, A. Billiau, A. Burny, and R. Kettmann. 1990. Cooperation between bovine leukemia virus transactivator protein and Ha-ras oncogene in cellular transformation. EMBO J. 9:1577-1581.
40. Willems, L., D. Portetelle, P. Kerkhofs, G. Chen, A. Burny, M. Mammerickx, and R. Kettmann. 1992. In vivo transfection of bovine leukemia virus mutants into sheep. Virology 189:775-777.
41. Willems, L., R. Kettman, R. Dequiedt, D. Portetelle, V. Voneche, I. Cornil, P. Kerkhofs, A. Burny, and M. Mammerickx. 1993. In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 67:4078-4085.
42. Willems, L., P. Kerkhofs, F. Dequiedt, D. Portetelle, M. Mammerickx, A. Burny, and R. Kettmann. 1994. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc. Natl. Acad. Sci. USA 91:11532-11536.
43. Wyatt, C., D. Wingett, J. White, C. Buck, D. Knowles, R. Reeves, and N. Magnuson. 1989. Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction. J. Virol. 63:4498-4506.
44. Yip, M. T., W. S. Dynan, P. L. Green, A. C. Black, S. J. Arrigo, A. Torbati, S. Heaphy, C. Ruland, J. D. Rosenblatt, and I. S. Y. Chen. 1991. Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element. J. Virol. 65:2261-2272.